Srinivas Akkaraju

Insider Reports History

Location
Palo Alto, CA
Signature
/s/ Srinivas Akkaraju
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Srinivas Akkaraju:

Form 4 holding Director

ALUMIS INC.

Security class
Common Stock
Shares / value
4,491,731
Estimated value
$43,839,743
Report date
09 Jan 2026
Price
$9.76
Ownership
By Samsara BioCapital, L.P.
Form 4 holding Director

ALUMIS INC.

Security class
Common Stock
Shares / value
1,853,488
Estimated value
$31,509,296
Report date
09 Jan 2026
Price
$17.00
Ownership
By Samsara Opportunity Fund, L.P.
Form 4 holding Director

vTv Therapeutics Inc.

Security class
Pre-Funded Warrants (Right to Buy)
Shares / value
1,548,101
Estimated value
$23,221,515
Report date
22 Sep 2025
Price
$15.00
Ownership
By Samsara BioCapital, L.P.
Underlying class
Class A Common Stock
Underlying amount
1,548,101
Form 4 holding Director

vTv Therapeutics Inc.

Security class
Warrant (Right to Buy)
Shares / value
983,214
Estimated value
$14,748,210
Report date
22 Sep 2025
Price
$15.00
Ownership
By Samsara Opportunity Fund, L.P.
Underlying class
Class A Common Stock
Underlying amount
983,214
Form 4 holding Director

vTv Therapeutics Inc.

Security class
Pre-Funded Warrants (Right to Buy)
Shares / value
877,214
Estimated value
$13,158,210
Report date
22 Sep 2025
Price
$15.00
Ownership
By Samsara Opportunity Fund, L.P.
Underlying class
Class A Common Stock
Underlying amount
877,214
Form 4 holding Director

vTv Therapeutics Inc.

Security class
Pre-Funded Warrants (Right to Buy)
Shares / value
1,548,101
Estimated value
$10,532,420
Report date
03 Sep 2025
Price
$11.80
Ownership
Samsara BioCapital, L.P.
Underlying class
Class A Common Stock
Underlying amount
Form 4 holding Director

vTv Therapeutics Inc.

Security class
Warrant (Right to Buy)
Shares / value
655,523
Estimated value
$9,832,845
Report date
22 Sep 2025
Price
$15.00
Ownership
By Samsara BioCapital, L.P
Underlying class
Class A Common Stock
Underlying amount
655,523
Form 4 holding Director

Syros Pharmaceuticals, Inc.

Security class
Restricted Stock Units
Shares / value
2,667
Estimated value
$4,470
Report date
16 Sep 2024
Price
$1.68
Ownership
Direct
Underlying class
Common Stock
Underlying amount
Form 4 holding Director, 10%+ Owner

Jiya Acquisition Corp.

Security class
Class B Common Stock
Shares / value
2,437,114
Estimated value
Report date
23 Sep 2022
Price
Ownership
Indirect
Underlying class
Class A Common Stock
Underlying amount
Form 4 holding Director

vTv Therapeutics Inc.

Security class
Warrant to Purchase Class A Common Stock (Right to Buy)
Shares / value
655,523
Estimated value
Report date
03 Sep 2025
Price
Ownership
By Samsara BioCapital, L.P.
Underlying class
Class A Common Stock
Underlying amount
Form 4 holding Director

ALUMIS INC.

Security class
Stock Option (Right to Buy)
Shares / value
49,800
Estimated value
Report date
30 Jul 2025
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount
Form 4 holding Director, 10%+ Owner

Kalaris Therapeutics, Inc.

Security class
Stock Option (Right to Buy)
Shares / value
18,000
Estimated value
Report date
10 Apr 2025
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount
Form 4 holding Director

Syros Pharmaceuticals, Inc.

Security class
Stock Option (right to buy)
Shares / value
6,000
Estimated value
Report date
05 Jun 2024
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount
Form 4 holding Director

CHINOOK THERAPEUTICS, INC.

Security class
Common Stock
Shares / value
0
Estimated value
Report date
11 Aug 2023
Price
$39.03
Ownership
By Samsara BioCapital, L.P.
Form 4 holding Director

CHINOOK THERAPEUTICS, INC.

Security class
Stock Option (Right to Buy)
Shares / value
0
Estimated value
Report date
11 Aug 2023
Price
$26.12
Ownership
Direct
Underlying class
Common Stock
Underlying amount
Form 4 holding Director

INTERCEPT PHARMACEUTICALS, INC.

Security class
Option to Purchase Common Stock
Shares / value
0
Estimated value
Report date
08 Nov 2023
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount
Form 4 holding Director

Scholar Rock Holding Corp

Security class
Warrants to Purchase Common Stock
Shares / value
0
Estimated value
Report date
12 Dec 2025
Price
Ownership
By Samsara BioCapital LP
Underlying class
Common Stock
Underlying amount

Insider Reports Filed by Srinivas Akkaraju

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .